Preconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literature

dc.creatorGuarda, Francisco J.
dc.creatorGong, W.
dc.creatorGhajar, A.
dc.creatorGuitelman, M.
dc.creatorNachtigall, L. B.
dc.date.accessioned2022-11-09T15:04:47Z
dc.date.available2022-11-09T15:04:47Z
dc.date.created2022-11-09T15:04:47Z
dc.date.issued2020
dc.identifier10.1007/s11102-020-01050-2
dc.identifier1573-7403
dc.identifier1386-341X
dc.identifierhttps://doi.org/10.1007/s11102-020-01050-2
dc.identifierhttps://repositorio.uc.cl/handle/11534/65396
dc.languageen
dc.rightsacceso restringido
dc.subjectAcromegaly
dc.subjectPegvisomant
dc.subjectPregnancy
dc.subjectPituitary
dc.subjectGrowth hormone
dc.subjectIGF-1
dc.titlePreconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literature
dc.typeartículo


Este ítem pertenece a la siguiente institución